Latest Insider Transactions at Tenaya Therapeutics, Inc. (TNYA)
This section provides a real-time view of insider transactions for Tenaya Therapeutics, Inc. (TNYA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Tenaya Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Tenaya Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 26
2022
|
Timothy Hoey Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,353
-0.68%
|
$13,530
$10.13 P/Share
|
|
Aug 03
2021
|
Jeen Joo Kang Director |
BUY
Conversion of derivative security
|
Direct |
12,500
+33.33%
|
-
|
|
Aug 03
2021
|
David V Goeddel |
BUY
Conversion of derivative security
|
Indirect |
9,346,124
+49.86%
|
-
|
|
Aug 03
2021
|
Eli Casdin Director |
BUY
Conversion of derivative security
|
Indirect |
2,736,818
+50.0%
|
-
|
|
Aug 03
2021
|
Eli Casdin Director |
BUY
Open market or private purchase
|
Indirect |
850,000
+20.86%
|
$12,750,000
$15.0 P/Share
|
|
Aug 03
2021
|
Column Group Iii Gp, LP |
BUY
Conversion of derivative security
|
Indirect |
9,346,124
+49.86%
|
-
|
|
Aug 03
2021
|
Casdin Partners Master Fund, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,736,818
+50.0%
|
-
|
|
Aug 03
2021
|
Casdin Partners Master Fund, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
850,000
+20.86%
|
$12,750,000
$15.0 P/Share
|